|
|
Dormidina Sleeping
Tablets |
|
|
Dormidina ® 25 doxylamine succinate
COMPOSITION
Each Tablet contains: Doxylamine (INN) succinate……25 mg
Excipients: dibasic calcium phosphate, microcrystalline
cellulose, sodium starch glycolate, colloidal silicon
dioxide, magnesium stearate, propylene glycol, titanium
dioxide (E-171) blue coating (E-132), hidroxypropylmethyl
cellulose, cellulose derivative and polyoxyl-40 stearate
and polyethylene glycol 8000, q.s
PROPERTIES
Doxylamine, the active ingredient of Dormidina 25, has
a quick acting sedative and sleep-inducing effect.
INDICATIONS
It is useful in the symptomatic treatment of all forms
of insomnia, particularly associated with difficulties
in falling asleep, frequent interruptions of sleep or
early wakening. Its efficacy is already apparent after
the first night time dose.
DOSAGE
The dose recommended for adults (over 18 years of age)
is 1 tablet (25mg) given 30 minutes before going to bed.
For young people under 18 years of age: consult your doctor.
CONTRAINDICATIONS
Dormidina 25 should not be used in people with asthma,
glaucoma (increased intraocular pressure), prostate hypertrophy
or patients with a history of hypersensitivity to any
of its components. It should not be given to pregnant
or lactating women.
PRECAUTIONS
It is recommended to take Dormidina 25 only when going
to bed. Do not drive or handle dangerous machinery while
taking this medicine.
WARNING
Use with caution if you drink alcohol or are taking medicines
with ethanol as these may enhance the drug's sedative
effect. It you are receiving treatment with another drug,
you should consult your doctor before taking Dormidina
25. It should not be taken for periods exceeding 2 weeks
or given to people under 18 years of age without the doctor's
knowledge and recommendation.
Important for women: It you are pregnant or think you
might be, consult your doctor before taking this medicine.
The consumption of medicines during pregnancy may be dangerous
for the embryo or foetus and should be monitored by your
doctor.
It may interfere with skin tests that use allergens. It
is recommended to stop taking this medication at least
three days before starting these tests and that you inform
your doctor.
INTERACTIONS
None have been described.
SIDE EFFECTS
Occasionally dry mouth and cloudy vision have been observed.
In most cases, the side effects reported have been mild
and have not required stopping treatment. If you feel
drowsy the next morning, reduce the dose.
OVERDOSE AND ITS TREATMENT
In the event of massive intake, treatment should be symptomatic
and aimed at maintaining vital functions, with endotracheal
intubations if necessary. In the event of overdose or
accidental intake, consult the Toxicological Information
Service.
PRESENTATION
Boxes containing 16 coated Tablets with 25 mg.
OTHER PRESENTATIONS
Dormidina 12,5. Boxes containing 16 coated Tablets with
12,5 mg. Dormidina sachets. Boxes with 10 sachets containing
effervescent powder with 25 mg.
---------- WITHOUT MEDICAL PRESCRIPTION ----------
ALL MEDICATIONS MUST BE KEPT OUT
OF THE REACH OF CHILDREN |
|
|
|
